$25,000 Centenary Institute Lawrence Creative Prize goes to young Melbourne researcher
One of Australia’s most creative young medical researchers has won a $25,000 prize to help her develop her ideas on how diet could prevent stroke deaths.
Connie Wong thinks we may be able to prevent early deaths following stroke with a fibre-based diet. She initially used innovative microscope techniques to determine how stroke weakens the immune system. Now she is studying how it also induces leakiness in the gut wall, leading to infection and an upsurge in deaths. And the solution may well lie in diet.
Centenary Institute Lawrence Creative Prize to be announced, finalists from Melbourne and Sydney
The winner of the Centenary Institute Lawrence Creative Prize will be announced at 6.30 pm, Tuesday 12 November 2013, at a reception hosted by UBS in Sydney.
There are three finalists. On Tuesday we will find out who is the overall winner of the $25,000 prize. The two runners-up will each receive $5,000.
When enzyme inhibiting drugs to treat diabetes were being developed, Mark Gorrell warned that care was needed to ensure the drugs targeted a specific enzyme, leaving other members of the enzyme family unaffected.
Thankfully, his warning was heeded by drug companies.
Associate Professor Mark Gorrell and his team of liver researchers at Sydney’s Centenary Institute have now confirmed that the diabetes drugs and potential cancer therapies based on regulating the dipeptidyl peptidase (DPP) family of enzymes must be carefully targeted to avoid serious side effects such as skin and intestinal damage.
Centenary’s discoveries lead to a commercial agreement to create drugs to fix leaking blood vessels
Australian molecular biologists led by researchers at Centenary have made a synthetic compound that appears to allow them to control the leakiness of blood vessels. The work could lead to effective new drug treatments for strokes and tumours. Spinoffs may include an ability to reduce the side-effects of chemotherapy and inflammation.
Their lead drug candidate, known as CD5-2, was developed with the assistance of Mirrx Therapeutics, a privately owned Danish biotechnology company. Today Centenary has signed an agreement to develop this and other potential drugs with Mirrx. The agreement was facilitated by Bio-Link Australia Pty Ltd.
Ramaciotti invests $1 million in a new approach to understanding human disease
“We’ll be able to ask individual immune cells where they’ve been and who they’ve been talking to…”
The University of Sydney and The Centenary Institute will establish the Ramaciotti Centre for Human Systems Biology in 2014 following the announcement earlier this evening of the $1 million Ramaciotti Biomedical Research Award.
‘The Holst effect’ opens up new therapeutic options for prostate cancer treatment.
24 September 2013
A team of researchers from Sydney, Vancouver, Adelaide and Brisbane are getting closer to a new treatment for prostate cancer that relies on starving tumours of essential nutrients they need to grow.
In work just published in the Journal of the National Cancer Institute, Dr Jeff Holst, from Sydney’s Centenary Institute and his colleagues have shown they can slow the growth of the cancer by blocking the proteins which pump the amino acid leucine into tumour cells.
We’re looking for early-career scientists in biomedical research with a uniquely creative way of significantly contributing to their chosen field. [continue reading…]
Researchers from the Gene and Stem Cell Therapy Program at Sydney’s Centenary Institute have confirmed that, far from being “junk”, the 97 per cent of human DNA that does not encode instructions for making proteins can play a significant role in controlling cell development.
And in doing so, the researchers have unravelled a previously unknown mechanism for regulating the activity of genes, increasing our understanding of the way cells develop and opening the way to new possibilities for therapy.
Australian liver disease specialists available for World Hepatitis Day interviews
Exciting early indications of a cure for Hepatitis C do not mean we should become complacent about the risks of contracting the debilitating disease, a leading Australian researcher warns.
Professor Geoff McCaughan, head of the Liver Immunobiology Program at Sydney’s Centenary Research Institute, says preliminary results of a newly developed oral treatment regime for liver transplant patients with Hepatitis C were showing promising results.
We are a team of science writers, publicists, communicators and editors.
We help you communicate complex ideas simply to the public, media, government and industry.
We work on all platforms from social media, to media, pitches, publications, events and conferences.
Scientists: if you need help with your research communication;
Journalists: if you’re looking for talent for your next story; you’re in the right place.
Media and communication training
Full day hands-on workshops in small groups. Practise interviews with journalists. Find your key messages. Handle tricky questions. Learn how to ensure your research is reported accurately.
Sarah's structure of the course, specific insight and understanding of science, her contacts and common mistakes made in communication were great and furthered my skills in this area.
Anonymous - Sydney Jan 2020
Science In Public
2020-01-28T15:04:28+11:00
Anonymous - Sydney Jan 2020
Sarah's structure of the course, specific insight and understanding of science, her contacts and common mistakes made in communication were great and furthered my skills in this area.
This is one of the best science communication courses I have ever encountered. It teaches all research to think out of box and really simplify their research in lay man's language. I will highly recommend this to anyone looking to learn more about science communication.
Shwathy Ramesh
Science In Public
2020-02-24T09:29:55+11:00
Shwathy Ramesh
This is one of the best science communication courses I have ever encountered. It teaches all research to think out of box and really simplify their research in lay man's language. I will highly recommend this to anyone looking to learn more about science communication.
Sufficient time given to work one-on-one with each participant. TV, radio and newspaper given sufficient weight. Practical, informative and professional
Anonymous - Gold Coast May 2021
Science In Public
2022-09-05T12:59:42+10:00
Anonymous - Gold Coast May 2021
Sufficient time given to work one-on-one with each participant. TV, radio and newspaper given sufficient weight. Practical, informative and professional
Good mix in terms of topics covered, people invited and media coverage. This course will make me more comfortable and I believe it will improve my confidence about myself and how I talk about my work in front of media.
FEnEX CRC, December 2021
Science In Public
2022-09-05T13:01:49+10:00
FEnEX CRC, December 2021
Good mix in terms of topics covered, people invited and media coverage. This course will make me more comfortable and I believe it will improve my confidence about myself and how I talk about my work in front of media.
Sarah is an amazing instructor. She has looked after each of the participants very well. I really like her style. Thank you to all team for a valuable training session.
Seyhan Yazar, Garvan Institute of Medical Reseearch
Science In Public
2022-09-05T13:02:58+10:00
Seyhan Yazar, Garvan Institute of Medical Reseearch
Sarah is an amazing instructor. She has looked after each of the participants very well. I really like her style. Thank you to all team for a valuable training session.
Pushed me to finesse/develop a pitch, find an edge that will facilitate communicating my research findings. The real world experience/opportunity for interviews was exceptionally helpful
Megan Bater
Science In Public
2022-09-05T13:06:38+10:00
Megan Bater
Pushed me to finesse/develop a pitch, find an edge that will facilitate communicating my research findings. The real world experience/opportunity for interviews was exceptionally helpful
The day was a great balance of topics and presented in an approachable and friendly style that was very inclusive. It was a fantastic and informative session that will really help me day-to-day in the communications work I do.
Ben Westmoreland, 2022
Science In Public
2022-09-05T13:07:28+10:00
Ben Westmoreland, 2022
The day was a great balance of topics and presented in an approachable and friendly style that was very inclusive. It was a fantastic and informative session that will really help me day-to-day in the communications work I do.